Cwm, LLC Amicus Therapeutics, Inc. Transaction History

Cwm, LLC

$21.2 Billion
Q2 2024

A detailed history of Cwm, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 1,443 shares of FOLD stock, worth $16,868. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,443

Previous 1,752 17.64%

Holding current value

$16,868

Previous $21,000 33.33%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	SELL	$9.04 - $11.75 $2,793 - $3,630	-309 Reduced 17.64%	1,443 $14,000
Q1 2024 Apr 05, 2024	BUY	$11.43 - $14.24 $605 - $754	53 Added 3.12%	1,752 $21,000
Q4 2023 Feb 01, 2024	SELL	$9.97 - $14.52 $488 - $711	-49 Reduced 2.8%	1,699 $24,000
Q3 2023 Oct 11, 2023	BUY	$11.78 - $13.86 $871 - $1,025	74 Added 4.42%	1,748 $21,000
Q2 2023 Aug 03, 2023	BUY	$10.72 - $13.3 $4,845 - $6,011	452 Added 36.99%	1,674 $21,000
Q1 2023 Apr 28, 2023	BUY	$10.91 - $13.54 $327 - $406	30 Added 2.52%	1,222 $14,000
Q4 2022 Feb 01, 2023	SELL	$9.89 - $12.7 $98 - $127	-10 Reduced 0.83%	1,192 $15,000
Q2 2022 Jul 28, 2022	SELL	$6.23 - $11.12 $1,358 - $2,424	-218 Reduced 15.35%	1,202 $13,000
Q1 2022 Apr 21, 2022	SELL	$7.89 - $12.48 $355 - $561	-45 Reduced 3.07%	1,420 $13,000
Q4 2021 Jan 31, 2022	SELL	$9.82 - $12.44 $1.51 Million - $1.92 Million	-154,040 Reduced 99.06%	1,465 $17,000
Q1 2021 Sep 15, 2021	BUY	$9.2 - $23.86 $68,972 - $178,878	7,497 Added 5.07%	155,505 $1.5 Million
Q1 2021 Apr 27, 2021	SELL	$9.2 - $23.86 $68,972 - $178,878	-7,497 Reduced 4.82%	148,008 $1.46 Million
Q4 2020 Sep 15, 2021	BUY	$13.47 - $24.89 $218,671 - $404,064	16,234 Added 11.66%	155,505 $1.5 Million
Q4 2020 Jan 27, 2021	SELL	$13.47 - $24.89 $218,671 - $404,064	-16,234 Reduced 10.44%	139,271 $3.22 Million
Q3 2020 Sep 15, 2021	BUY	$12.89 - $15.89 $2 Million - $2.47 Million	155,426 Added 196741.77%	155,505 $1.5 Million
Q3 2020 Oct 19, 2020	SELL	$12.89 - $15.89 $2 Million - $2.47 Million	-155,426 Reduced 99.95%	79 $1,000
Q2 2020 Sep 15, 2021	BUY	$8.86 - $15.69 $1.38 Million - $2.44 Million	155,426 Added 196741.77%	155,505 $1.5 Million
Q2 2020 Jul 22, 2020	SELL	$8.86 - $15.69 $1.38 Million - $2.44 Million	-155,426 Reduced 99.95%	79 $1,000
Q1 2020 Sep 15, 2021	BUY	$6.63 - $11.16 $1.03 Million - $1.73 Million	155,426 Added 196741.77%	155,505 $1.5 Million
Q1 2020 Apr 28, 2020	SELL	$6.63 - $11.16 $1.03 Million - $1.73 Million	-155,426 Reduced 99.95%	79 $1,000
Q4 2019 Sep 14, 2021	BUY	$7.48 - $10.75 $1.16 Million - $1.67 Million	155,257 Added 62603.63%	155,505 $1.5 Million
Q4 2019 Jan 27, 2020	SELL	$7.48 - $10.75 $1.16 Million - $1.67 Million	-155,257 Reduced 99.84%	248 $2,000
Q3 2019 Sep 14, 2021	BUY	$8.02 - $13.25 $1.25 Million - $2.06 Million	155,505 New	155,505 $1.5 Million
Q3 2019 Oct 22, 2019	SELL	$8.02 - $13.25 $1.25 Million - $2.06 Million	-155,505 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$10.96 - $14.4 $1.7 Million - $2.24 Million	155,505 New	155,505 $1.5 Million
Q2 2019 Jul 31, 2019	SELL	$10.96 - $14.4 $1.7 Million - $2.24 Million	-155,505 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$10.04 - $13.92 $1.55 Million - $2.15 Million	154,540 Added 16014.51%	155,505 $0
Q4 2018 Jan 25, 2019	BUY	$8.38 - $13.44 $8,086 - $12,969	965 New	965 $9,000

Others Institutions Holding FOLD

# of Institutions

279

Shares Held

324M

Call Options Held

260K

Put Options Held

261K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $3.28B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account